A 67-year-old man pauses halfway through getting dressed, his legs suddenly too weak to hold him up. His wife says he has barely urinated since yesterday; the bedside monitor now shows a broad, oddly peaked rhythm. His potassium result is still pending, and the team must decide whether to wait for it.

— What’s your move? Read on.

Before you read
  • What must happen before insulin is used to lower potassium?
  • When is oral rather than IV potassium replacement appropriate?

When to Think of It

Consider potassium disturbance with weakness, paralysis, palpitations, syncope, renal failure, missed dialysis, tissue breakdown, or use of potassium-altering medications. Hyperkalemia may cause peaked T waves, PR prolongation, loss of P waves, QRS widening, or a sine-wave pattern; hypokalemia may cause flattened T waves, ST depression, U waves, and ectopy. ECG findings are not sensitive enough to exclude danger.

Sick or Not Sick

The decision that matters most: Is there an unstable rhythm or concerning ECG change, or severe potassium abnormality? Treat hyperkalemic ECG toxicity immediately; severe hypokalemia (often <2.5 mEq/L), symptoms, or ECG changes also requires monitored urgent replacement. Confirm unexpected results, but do not delay stabilization for a dangerous ECG.

The First Fifteen Minutes

  • Hyperkalemia with ECG changes, arrhythmia, or instability → calcium gluconate 1 g IV over 2–5 minutes; repeat ECG and repeat calcium in 5–10 minutes if changes persist. Calcium stabilizes myocardial membranes but does not lower potassium. For peri-arrest or central access, calcium chloride 1 g IV may be used; it is more caustic if extravasated.
  • Severe hyperkalemia requiring intracellular shift → regular insulin 10 units IV plus dextrose 25 g IV (unless markedly hyperglycemic); insulin shifts potassium into cells. Check glucose frequently for at least 4–6 hours because hypoglycemia can be delayed.
  • Additional shift for severe hyperkalemia → albuterol 10–20 mg by nebulizer; beta-2 stimulation drives potassium intracellularly. It is an adjunct, not a substitute for calcium or definitive potassium removal.
  • Hyperkalemia with severe acidemia → sodium bicarbonate 50 mEq IV may be considered when significant metabolic acidemia is present; its benefit is limited otherwise, so follow local protocol and reassess.
  • Hypokalemia, stable and able to take oral medication → potassium chloride 40 mEq PO, then recheck and repeat according to level and deficit; oral replacement is safer and more predictable.
  • Hypokalemia requiring IV replacement → potassium chloride 10 mEq/h IV through a peripheral line (up to 20 mEq/h centrally with continuous ECG monitoring and institutional protocol). Never give IV potassium as a push.
  • Obtain ECG, point-of-care glucose, renal function, magnesium, and repeat potassium if the result is unexpected or hemolysis is suspected. Place patients receiving rapid IV replacement or treatment for severe hyperkalemia on continuous monitoring.

Definitive Care & Disposition

Recheck potassium after temporizing therapy—shifting is not removal. Arrange definitive removal for hyperkalemia: dialysis for refractory or severe cases, particularly with renal failure; potassium binders may be adjuncts but are not reliable emergency monotherapy. Treat the cause (e.g., medication effect, tissue breakdown, or renal failure). Admit to a monitored setting for ECG changes, severe abnormalities, ongoing IV replacement, or need for dialysis; discharge only after stable repeat values, a corrected cause, and a safe follow-up plan.

How This One Kills

Mistaking a temporary intracellular shift for potassium removal. Insulin and albuterol wear off; without repeat testing and definitive elimination, potassium rebounds and the arrhythmia returns.
The Differential — What Else Looks Like This
  • Pseudohyperkalemia — hemolysis or a difficult draw with a normal ECG and repeat nonhemolyzed sample; treating an artifact can cause dangerous hypokalemia.
  • Acute coronary syndrome — ischemic ST changes and symptoms rather than a typical potassium progression; confusing it with hyperkalemia delays reperfusion.
  • Hypomagnesemia — persistent or refractory hypokalemia despite replacement; missing it makes potassium correction ineffective and arrhythmia risk persist.
  • Periodic paralysis — episodic weakness with potassium shift and often a compatible trigger; large empiric potassium doses can cause rebound hyperkalemia.

The Second-Day Story

Older adults and patients with renal disease may have no palpitations or weakness despite dangerous hyperkalemia; the first clue may be a routine chemistry result or subtle conduction change. Conversely, patients with hypokalemia may report fatigue, constipation, or difficulty walking rather than paralysis. Review renal function, medication and dialysis history, and the ECG, and verify suspicious laboratory results—but never use a reassuring ECG to dismiss a clearly severe potassium level.
Back to Our Patient
Back to our patient: the 67-year-old with oliguria, leg weakness, and broad peaked T waves has a dangerous hyperkalemic ECG pattern, so treatment cannot wait for the pending result. Recognize the likely potassium emergency, risk-stratify him as unstable until proven otherwise, and place him on continuous monitoring while giving IV calcium gluconate, then insulin with dextrose and nebulized albuterol. Repeat ECG and potassium, investigate renal failure and missed dialysis, and arrange urgent definitive potassium removal. He needs monitored admission and likely dialysis, not discharge after a transient ECG improvement.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 67-year-old man presenting with acute leg weakness and markedly reduced urine output since yesterday. His wife reports no known overdose, and he denies chest pain or palpitations, but the monitor shows broad QRS complexes with peaked T waves. He is weak but awake; the ECG is concerning for potassium-related conduction toxicity, and his chemistry is pending. I’m treating presumed severe hyperkalemia now with IV calcium, followed by insulin with dextrose and nebulized albuterol, while monitoring glucose and rhythm. I’ll repeat the ECG and potassium, assess renal function and dialysis history, and involve nephrology early. Given the ECG changes and oliguria, he requires monitored admission and likely urgent dialysis.”

Study Directive

  • Draw the hyperkalemia ECG progression from memory and state the first action for each dangerous finding.
  • Practice calculating an insulin/dextrose hyperkalemia order and writing the glucose-monitoring plan.
  • Review your institution’s potassium infusion limits, monitoring requirements, and escalation pathway for dialysis.

Recent Literature

  • Review or guideline Potassium and the kidney
    Hoorn EJ, Subramanya AR, Boyd-Shiwarski CR · Nat Rev Nephrol, 2026 · PMID 41611896 · cited 2×
    Understanding how the kidney regulates potassium helps residents identify renal causes of dyskalemia and anticipate dangerous shifts when kidney function is impaired.